ArticleFrontiers in oncology2022

Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients' overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study.

Fuqiang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.